Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Ring

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
BMJ Open|May 14, 2021
Predicting outcome following mild traumatic brain injury: protocol for the longitudinal, prospective, observational Concussion Recovery (<i>CREST</i>) cohort studyAleksandra Karolina Gozt, Sarah Claire Hellewell, Jacinta Thorne, et al.
Nature Communications|October 12, 2023
Proteogenetic drug response profiling elucidates targetable vulnerabilities of myelofibrosisMattheus H E Wildschut, Julien Mena, Cyril Dördelmann, et al.
Nature Medicine|January 24, 2025
Digoxin for reduction of circulating tumor cell cluster size in metastatic breast cancer: a proof-of-concept trialChristian Kurzeder, Bich Doan Nguyen-Sträuli, Ilona Krol, et al.
Nature Medicine|October 16, 2025
Macrovascular tumor infiltration and circulating tumor cell cluster dynamics in patients with cancer approaching the end of lifeKelley Newcomer, Alessandro Bifolco, Sarah Reeves, et al.
Nature Medicine|May 27, 2025
Feasibility of multiomics tumor profiling for guiding treatment of melanomaNicola Miglino, Nora C Toussaint, Alexander Ring, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
BMJ Open|May 14, 2021
Predicting outcome following mild traumatic brain injury: protocol for the longitudinal, prospective, observational Concussion Recovery (<i>CREST</i>) cohort studyAleksandra Karolina Gozt, Sarah Claire Hellewell, Jacinta Thorne, et al.
Nature Communications|October 12, 2023
Proteogenetic drug response profiling elucidates targetable vulnerabilities of myelofibrosisMattheus H E Wildschut, Julien Mena, Cyril Dördelmann, et al.
Nature Medicine|January 24, 2025
Digoxin for reduction of circulating tumor cell cluster size in metastatic breast cancer: a proof-of-concept trialChristian Kurzeder, Bich Doan Nguyen-Sträuli, Ilona Krol, et al.
Nature Medicine|October 16, 2025
Macrovascular tumor infiltration and circulating tumor cell cluster dynamics in patients with cancer approaching the end of lifeKelley Newcomer, Alessandro Bifolco, Sarah Reeves, et al.
Nature Medicine|May 27, 2025
Feasibility of multiomics tumor profiling for guiding treatment of melanomaNicola Miglino, Nora C Toussaint, Alexander Ring, et al.
Pageof 5